Popular weight loss drug, Ozempic, tied to stomach paralysis ( "gastroparesis")side effects
Ozempic is a medication primarily prescribed for type 2 diabetes management, not weight loss per se. It received FDA approval in 2017 and is being prescribed off label for weight loss taken by many thousands of people. The issue is that since the FDA approved Ozempic in 2017, the manufacturer, Novo Nordisk ,has not included gastroparesis warnings in its prescription information. The company warned about other Ozempic side effects but didn’t warn the public of the risk of severe gastroparesis. There is no cure for gastroparesis, and now a growing number of those injured are seeking compensation for loss of quality of life, past and future medical bills and other damages. Brand names involved include: Mounjaro Rybelsus Saxenda Wegovy For severe cases, it is also advisable to contact a Law Firm that can further advise and file a case where warranted to seek appropriate compensation. If you live in Connecticut, Rhode Island or Massachusetts , a local New England based Firm may be a good place to start. Case inquiries may be accepted in other jurisdictions as well